In vitro effect of N-acetyl-L-cysteine on glutathione and sulfhydryl levels in X-linked adrenoleukodystrophy patients
Palavras-chave:
X- linked adrenoleukodystrophy, N-acetyl-L-cysteine, glutathione, sulfhydrylResumo
Introduction: Recent evidence shows that oxidative stress seems to be related with the pathophysiology of X-linked adrenoleukodystrophy (X-ALD), a neurodegenerative disorder. Methods: In the present study, the in vitro effect of N-acetyl-L-cysteine (NAC) on glutathione (GSH) and sulfhydryl levels in X-ALD patients was evaluated. Results: A significant reduction of GSH and sulfhydryl content was observed in X-ALD patients compared to the control group. Furthermore, 5 mM of NAC, in vitro, led to an increase in GSH content and sulfhydryl groups in these patients. Conclusion: These data probably indicate that an adjuvant therapy with the antioxidant NAC could improve the oxidative imbalance in X-ALD patients.
Keywords: X- linked adrenoleukodystrophy; N-acetyl-L-cysteine; glutathione; sulfhydryl
Downloads
Referências
Moser HW, Smith KD, Watkins PA, Powers J, Moser AB. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, edithors. The Metabolic and Molecular Bases of Inherited Disease, 8th ed., New York: McGraw-Hill Inc; 2001. p. 3257-3301.
Berger J, Forss-Petter S, Eichler FS. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014; 98:135-142.
Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R, Aubourg P, Ferrer I, Pujol A. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: A paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta. 2012; 1822:1475-1488.
Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta. 2004; 1688:26-32.
Petrillo S, Piemonte F, Pastore A, Tozzi G, Aiello C, Pujol A, et al. Glutathione imbalance in patients with X-linked adrenoleukodystrophy. Mol Genet Metab. 2013; 109:366-370.
Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003; 60:6-20.
Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg Leonore A. N-
Acetylcysteine: a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007; 7:355-359.
Di Biase A, Benedetto R, Salvati S, Attorri L, Leonardi F, Pietraforte D. Effects of L-mono methy-arginine, N-acetyl-L-cysteine and diphenyleniodonium on free radical release in C6 glial cells enriched in hexacosanoic acid. Neurochem Res. 2005; 30(2):215-223.
Galino J, Ruiz M, Fourcade S Schlüter A, López-Erauskin J, Guilera C, et al. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal. 2011; 15(8): 2095-2107.
López-Erauskin J, Fourcade S, Galino J, Ruiz M, Schlüter A, Naudi A, et al. Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy. Ann Neurol. 2011; 70:84-92.
Tolar J, Orchard PJ, Bjoraker KJ, Ziegler RS, Shapiro EG, Charnas L. N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant. 2007; 39: 211-215.
Abt G, Vaghef H, Gebhart E, Dahlgren CV, Hellman B. The role of N acetylcysteine as a putative radioprotective agent on X-ray-induced DNA damage as evaluated by alkaline single-cell gel electrophoresis. Mutat Res. 1997; 384:55-64.
Browne RW, Armstrong D. Reduced glutathione and glutathione disulfide. Methods Mol Biol. 1998; 108:347-352.
Aksenov MY, Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer’s disease. Neurosci Lett. 2001; 302:141-145.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265-275.
Deon M, Sitta A, Barschak AG, Coelho DM, Pigatto M, Schmitt GO, et al. Introduction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy. Int J Devl Neuroscience. 2007; 25:441-444.
Rockenbach FJ, Deon M, Marchese DP, Manfredini V, Mescka C,
Ribas GS, et al. The effect of bone marrow transplantation on oxidative stress in X-linked adrenoleukodystrophy. Mol Genet Metab. 2012; 106: 231-236.
Halliwell B, Gutteridge JMC. Free radicals in Biology and Medicine. Oxford: Oxford University Press; 2007.
Johnson WM, Wilson-Delfosse AL, Mieyal JJ. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients. 2012; 4:1399-1440.
Farr SA, Poon HF, Dogrukol-Ak, Drake J, Banks WA, Eyerman E, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003; 84:1173-1183.
Tchantchou F, Graves M, Rogers E, Ortiz D, Shea TB. N-acetyl-cysteine alleviates oxidative damage to central nervous system of ApoE-deficient mice following folate and vitamin E-deficiency. J Alzheimers Dis. 2005; 7:135-138.
Terrill JR, Radley-Crabb HG, Grounds MD, Arthur PG. N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis. Neuromuscul Disord. 2012; 22(5):427-434.
Holmay MJ, Terpstra M, Coles LD, Mishra U, Ahlskog M, Öz G. N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson’s Diseases. Clin Neuropharmacol. 2013; 36(4):103-106.
Rushworth GF, Megson IL. Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther. 2014; 141:150-159.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Autores que publicam nesta revista concordam com os seguintes termos:
- Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
- Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
- Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado (Veja O Efeito do Acesso Livre).
